The prevalence of diabetes in Paraguay has been on the rise in recent years, leading to an increased demand for anti-diabetes drugs in the country.
Customer preferences: Paraguayans are becoming more health-conscious and are actively seeking ways to manage their diabetes. As a result, there has been an increasing demand for anti-diabetes drugs that are effective in managing the condition while minimizing side effects. Patients are also looking for drugs that are affordable and easily accessible.
Trends in the market: The anti-diabetes drugs market in Paraguay is expected to grow steadily in the coming years. The market is dominated by multinational pharmaceutical companies that offer a range of drugs, including insulin and oral medications. However, there is also a growing interest in alternative therapies, such as herbal medicines and dietary supplements. Patients are increasingly looking for natural remedies that can help manage their diabetes alongside conventional drugs.
Local special circumstances: Paraguay is a developing country with a relatively low GDP per capita. As a result, many patients are unable to afford expensive anti-diabetes drugs. This has led to a growing demand for generic drugs, which are more affordable than branded drugs. In addition, there is a lack of awareness about diabetes and its management among the general population. This has led to a need for greater education and awareness campaigns to help people manage their diabetes effectively.
Underlying macroeconomic factors: The Paraguayan economy has been growing steadily in recent years, driven by a strong agricultural sector and increasing foreign investment. However, the country still faces significant challenges, including high levels of poverty and inequality. These factors have a significant impact on the healthcare sector, including the availability and affordability of anti-diabetes drugs. The government has taken steps to address these issues, including increasing investment in healthcare and implementing policies to improve access to essential medicines. However, there is still a long way to go to ensure that all Paraguayans have access to the healthcare they need.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
